As a result, T-cell activation occurred, which was accompanied by epitope spreading (evidenced by increases in CD8+ T-cells specific for the endogenous tumour antigens TRP-2 and gp100) and inhibition of tumour-induced peripheral tolerance. The gene discussed is PMEL; the disease is neoplasm.